Does TECLISTAMAB-CQYV Cause Joint stiffness? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Joint stiffness have been filed in association with TECLISTAMAB-CQYV. This represents 0.5% of all adverse event reports for TECLISTAMAB-CQYV.
8
Reports of Joint stiffness with TECLISTAMAB-CQYV
0.5%
of all TECLISTAMAB-CQYV reports
0
Deaths
7
Hospitalizations
How Dangerous Is Joint stiffness From TECLISTAMAB-CQYV?
Of the 8 reports, 7 (87.5%) required hospitalization.
Is Joint stiffness Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TECLISTAMAB-CQYV. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does TECLISTAMAB-CQYV Cause?
Cytokine release syndrome (406)
Immune effector cell-associated neurotoxicity syndrome (153)
Off label use (122)
Death (116)
Plasma cell myeloma (96)
Infection (83)
Neutropenia (74)
Fatigue (72)
Pyrexia (67)
Covid-19 (64)
What Other Drugs Cause Joint stiffness?
ADALIMUMAB (3,927)
ETANERCEPT (2,944)
METHOTREXATE (2,304)
TOFACITINIB (1,819)
TOCILIZUMAB (1,749)
ABATACEPT (1,385)
RITUXIMAB (1,366)
LEFLUNOMIDE (1,228)
HYDROXYCHLOROQUINE (1,206)
SULFASALAZINE (1,167)
Which TECLISTAMAB-CQYV Alternatives Have Lower Joint stiffness Risk?
TECLISTAMAB-CQYV vs TEDIZOLID
TECLISTAMAB-CQYV vs TEDUGLUTIDE
TECLISTAMAB-CQYV vs TEDUGLUTIDE\WATER
TECLISTAMAB-CQYV vs TEGAFUR
TECLISTAMAB-CQYV vs TEGAFUR\URACIL